Segments - Plant Genotyping Equipment Market by Applications (Breeding, Product Development, Plant Research, and Quality Assessment), End-users (Laboratory, Greenhouse, and Field), Equipments (Liquid Handler, Real-time PCR Instruments, DNA Analyzer, SNP Genotyping Equipment, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global plant genotyping equipment market size is anticipated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increasing demand of genotyping of plants.
Plant genotyping is a process of analysis of genetic makeup of plant. Next generation sequencing technology is used in the process of genotyping. Different ways have been developed by researchers to grow plants with high nutritional content and resistance to illnesses and environmental stress. Equipments used in plan genotyping focus on analysis, identification, and assessment of genetic markers in the plant.
Genotyping is done for better crop yield by changing or integrating the plants gene at molecular level as well as it is done for breeding process, and for the production of pest free plant. Introduction of more automated equipment is making the genotyping process hassle free, effective, and less time consuming.
The COVID-19 pandemic has brought negative impact on the market. During pandemic, travels ban imposed by government bodies across the globe resulted in disruption of supply chain of genotyping equipments. Additionally, imposition of lockdown resulted in temporarily shutdown of plant genotyping lab which is hampering the demand of equipments. The market is expected to recover by the end of 2021, as the lockdown is lifted and labs are operational.
The report on the global plant genotyping equipment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Plant Genotyping Equipment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Applications (Breeding, Product Development, Plant Research, and Quality Assessment), End-users (Laboratory, Greenhouse, and Field), and Equipments (Liquid Handler, Real-time PCR Instruments, DNA Analyzer, SNP Genotyping Equipment, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Evogene Ltd.; LGC Limited ; and Illumina, Inc. |
Based on applications, the market is segregated into breeding, product development, plant research, and quality assessment. The breeding segment is estimated to account for a significant market share during the forecast period attributed to the introduction of genotype by sequencing (GBS) tool is assisting in plant breeding to enhance crop yield and tolerance to stress. Moreover, new developments in GBS resulted in the development of the marker-assisted selection tool to speed up the plant breeding and crop improvement, which is driving the segment growth further. However, the product development segment is anticipated to grow at a high CAGR during the projected period attributed to the rapid development of next generation sequencing platform resulting in need of new genotypic equipments for routing genotyping assessment of plants.
On the basis of end-users, the global plant genotyping equipment market is divided into laboratory, greenhouse, and field. The laboratory segment is estimated to expand at robust growth rate during the forecast period owing to significant boost in the number of research laboratories using plant genotyping to study several fundamental and applied aspects of plants. On the other hand, the greenhouse segment is projected to expand at a considerable CAGR during the forecast period attributed to the increase in demand for genotyping equipments to be deployed in greenhouses for better yield and pest resistance plants.
Based on equipments, the market is fragmented into, liquid handler, real-time PCR instruments, DNA analyzer, SNP genotyping equipment, and others. The SNP genotyping equipment segment is expected to grow at a rapid pace during the forecast period attributed to the equipment helps in marker-supported selection programs that helps in improving or enhancing plant characteristics. However, the liquid handler segment is anticipated to expand at a substantial CAGR in the coming years due to the handler, which helps in aseptic transformation of liquid that leads to minimizing the risk of contamination while performing genotypic assay.
In terms of region, the global plant genotyping equipment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the projected period owing to growing investment in R&D centers by key players in the region for the development of advanced plant genotyping equipment. However, the Asia Pacific market is anticipated to grow at a rapid pace during the forecast period due to the increased need for improved variety of plant free from genetic disease as well as production of microbial and pests’ resistance plant in the region for better yield.
The global plant genotyping equipment market has been segmented on the basis of
Key players competing in the global plant genotyping equipment market are Evogene Ltd.; LGC Limited; and Illumina, Inc.
Companies are focusing on product development and innovation in genotyping equipments. Furthermore, companies are widely engaging in strategic partnership, merger & acquisition, new product launch, and collaborations to boost their market share and acquiring new buyers.
For instance, in January 2018, Illumina announce launch of the iSeq 100 Sequencing System. This sequencing system delivers exceptional data accuracy at low cost.
In March 2018, Integrated DNA Technologies Inc. the U.S. based supplier of custom nucleic acids is acquired by Danaher Corporation. IDT operates as a brand and standalone operating company and within Danaher Corporation. This acquisition strengthen the Danaher’s life science domain.